![Matej Mikulic](https://cdn.statcdn.com/static/../CMS/contactperson/ERI285_1713877581.png)
Time from oncology medicine approval to patient access in Europe 2024, by country
This statistic displays the average time between an oncology medicine gaining marketing authorization and patient access in European countries as of January 5, 2024. According to the data, in Germany the average time between authorization and access for oncology medicines (for drugs launched from 2019 to 2022) was 93 days, compared to over 900 days in Lithuania.